The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Share Ownership Plan

24 Dec 2020 07:00

RNS Number : 7519J
Bilby PLC
24 December 2020
 

24 December 2020

 

Bilby Plc ("the Company")

Establishment of a Joint Share Ownership Plan

Acquisition by Director of an award of Joint Ownership Interests and Issue of Shares under Joint Share Ownership Plan

Bilby Plc (AIM: BILB), a leading supplier of gas heating, electrical and building services, is pleased to announce the establishment of The Bilby Employees' Joint Share Ownership Plan ("the Plan"). The Plan is designed with a view to encouraging a direct interest in shares by senior employees on terms which provide an incentive to focus on share price growth. This is achieved by the participant's interest being limited to growth in share values in excess of a carry charge as set out below.

The maximum amount of Ordinary Shares which may be issued under the Plan, and including pursuant to any other Bilby employees' share schemes, shall not exceed 15 per cent of the issued share capital of the Company on the day of such issue. The rules of the Plan contain customary malus and clawback provisions. 

The first issue of Ordinary Shares was made under the Plan on 21st December 2020 of 250,000 new ordinary shares of 10 pence each in the Company ("Ordinary Shares"), representing 0.42 per cent. of the enlarged issued share capital of the Company. The 250,000 Ordinary Shares have been issued at a subscription price of 26 pence per Ordinary Share, being the closing price of an Ordinary Share in the Company on 18 December 2020, pursuant to the Plan.

The 250,000 Ordinary Shares have been issued into the respective joint beneficial ownership of (i) David Bullen and (ii) the trustee of The Bilby Employees' Share Trust ("the Trust") upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Mr Bullen, the Company and RBC cees Trustees Limited as trustee of the Trust ("the Trustee"). The subscription price has been paid by the Trust out of funds advanced to it by the Company.

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the Jointly Owned Shares above the initial market value (26 pence per Ordinary Share), less a "carrying cost" (equivalent to simple interest at 3 per cent per annum on the initial market value) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost. The Jointly Owned Shares will become vested if the participant remains with the Company for a minimum period of 3 years. In the event of a fall in the share price between the date of issue and vesting (or increases by less than the carrying cost) and the shares are sold, participating employees would be limited to a nominal participation in the sale proceeds at that share price.

Application has been made to the London Stock Exchange for the 250,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 30 December 2020.

Following Admission, the beneficial interests held by David Bullen will be:

 

 

 

Name of Director

 

 

No. of whole Shares in which the Director is interested

 

No. of Shares in which the Director has an interest under the terms of a JOA

 

 

 

David Bullen

1,474,487

250,000

 

 

 

The Company advises that, following Admission, the issued share capital of the Company will be 58,971,845 Ordinary Shares with one voting right each. The Company does not hold any shares in treasury.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries

 

Bilby Plc

Sangita Shah, Chairman

David Bullen, Chief Executive Officer

 

+44 (0)20 7796 4133

(via Hudson Sandler)

Canaccord Genuity Limited (Nominated Adviser and Sole Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Andrew Potts

Georgina McCooke

Sales:

Jonathan Barr

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Bullen

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

LEI

213800JDWVCVYWS87928

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

GB00BV9GHQ09

b)

Nature of the transaction

Issue of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

26p

250,000

d)

Aggregated information:

Aggregated volume

Price

250,000 Ordinary Shares issued at a price of 26 pence per Ordinary Share

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVXLFLBLLXFBV
Date   Source Headline
16th Jun 20214:46 pmRNSChange of name to Kinovo plc
24th May 20216:12 pmRNSDirector/PDMR Shareholding
12th May 20214:57 pmRNSDirector/PDMR Shareholding
6th May 202110:09 amRNSHolding(s) in Company
6th May 20217:00 amRNSYear-end trading update
15th Apr 20214:41 pmRNSSecond Price Monitoring Extn
15th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSDirector/PDMR Shareholding
23rd Mar 20214:16 pmRNSHolding(s) in Company
18th Mar 20212:01 pmRNSHolding(s) in Company
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20219:37 amRNSHolding(s) in Company
11th Mar 20219:11 amRNSDirector/PDMR Shareholding and Share Plan
8th Feb 20214:49 pmRNSHolding(s) in Company
28th Jan 20213:58 pmRNSHolding(s) in Company
24th Dec 20207:00 amRNSJoint Share Ownership Plan
1st Dec 20207:00 amRNSHalf Year results
13th Nov 20207:00 amRNSTrading update and Board restructure
14th Oct 20204:40 pmRNSHolding(s) in Company
12th Oct 20208:15 amRNSHolding(s) in Company
5th Oct 202011:04 amRNSReplacement: Holding(s) in Company
30th Sep 202011:33 amRNSHolding(s) in Company
30th Sep 202011:28 amRNSHolding(s) in Company
16th Sep 20206:07 pmRNSDirector/PDMR Shareholding
14th Sep 202011:34 amRNSResult of AGM
11th Sep 202010:07 amRNSBoard change
14th Aug 202011:08 amRNSHolding(s) in Company
14th Aug 202010:35 amRNSAnnual Report and Notice of AGM
27th Jul 20201:27 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSFull Year Results
16th Jul 20207:00 amRNSNotice of Results
26th May 20208:06 amRNSNew Banking Facilities
7th May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:44 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSYear-end and COVID-19 trading update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:41 pmRNSDirector/PDMR Shareholding
19th Dec 20197:00 amRNSInterim Results
3rd Dec 20194:48 pmRNSNotice of Results
25th Nov 20197:00 amRNSDirectorate Change
22nd Nov 20197:00 amRNSHolding(s) in Company
21st Nov 201912:07 pmRNSHolding(s) in Company
20th Nov 20195:40 pmRNSHolding(s) in Company
20th Nov 20194:40 pmRNSHolding(s) in Company
15th Nov 20198:02 amRNSResult of Fundraise
14th Nov 20194:52 pmRNSProposed Fundraise
28th Oct 20194:21 pmRNSResult of Annual General Meeting
30th Sep 201911:59 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.